L-lysine attenuates hepatic steatosis in senescence-accelerated mouse prone 8 mice

11Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Non-alcoholic hepatic steatosis is a phenotype of metabolic syndrome, and aging is a risk factor for this condition. Senescence-accelerated mouse prone 8 (SAMP8) is a murine model for studying aging-associated disorders. We here investigated the effect of dietary supplementation with L-lysine (Lys) on non-alcoholic hepatic steatosis in SAMP8 mice. Triglyceride (TG) and cholesterol (Chol) accumulated in the livers of SAMP8 mice fed a standard diet at 36 wk of age. However, intake of a Lys-rich diet for 2 mo prevented the accumulation of TG and Chol in the liver. Plasma alanine aminotransferase activity, an index of liver injury, was decreased by Lys. The mRNA expression levels of peroxisome proliferator-activated receptor gamma coactivator 1-α and carnitine palmitoyltransferase 1a, which regulate β-oxidation, were increased in the livers of SAMP8 mice fed the Lys-rich diet. Taken together, our study suggests dietary intake of Lys prevents hepatic steatosis by stimulating β-oxidation in SAMP8 mice.

Cite

CITATION STYLE

APA

Sato, T., Muramatsu, N., Ito, Y., Yamamoto, Y., & Nagasawa, T. (2018). L-lysine attenuates hepatic steatosis in senescence-accelerated mouse prone 8 mice. Journal of Nutritional Science and Vitaminology, 64(3), 192–199. https://doi.org/10.3177/jnsv.64.192

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free